And Peter J. Schmidt, MD

Opinion

Brexanolone approval ‘marks an important milestone’

Author:

And Peter J. Schmidt, MD

The NIMH calls the drug “a compelling example of successful bench-to-bedside translation of basic neuroscience findings to benefit patients.”

• Read More